Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Johnson and Johnson

    Tag: Johnson and Johnson

    You Searched For "johnson-and-johnson"
    Janssen pharma collaborates with Beth Israel Deaconess Medical Center for COVID-19 Vaccine Development

    Janssen pharma collaborates with Beth Israel Deaconess Medical Center for COVID-19 Vaccine Development

    Medical Dialogues Bureau14 March 2020 4:00 AM GMT
    Janssen's vaccine program will use the Janssen AdVac® and PER.C6® technologies that provide the ability to rapidly upscale production of an optimal...
    HC relief  to J&J: stays order directing co to pay Rs 230 crore on account of GST profiteering

    HC relief to J&J: stays order directing co to pay Rs 230 crore on account of GST profiteering

    Medical Dialogues Bureau5 March 2020 7:15 AM GMT
    It also said that prima facie the methodology used by NAPA to arrive at its finding of profiteering was "flawed".
    AstraZeneca leukemia drug Calquence gets USFDA okay

    AstraZeneca leukemia drug Calquence gets USFDA okay

    Medical Dialogues Bureau24 Nov 2019 4:30 AM GMT
    New Delhi: AstraZeneca said late on Thursday that the U.S. Food and Drug Administration (FDA) had given its go-ahead for the company's Calquence drug...
    JnJ enters series of new collaborations with Government, NGOs for ending TB in India by 2025

    JnJ enters series of new collaborations with Government, NGOs for ending TB in India by 2025

    Farhat Nasim31 Oct 2019 7:09 AM GMT
    Hyderabad: Johnson & Johnson(JnJ) recently announced the expansion of its tuberculosis (TB) program in India in advance of the 50th Union World...
    New tests shows NO sign of asbestos in recalled JnJ baby powder

    New tests shows NO sign of asbestos in recalled JnJ baby powder

    Medical Dialogues Bureau30 Oct 2019 7:48 AM GMT
    But Johnson & Johnson (JnJ) said in a statement that dozens of tests by two outside firms did not detect any asbestos in JnJ's baby powder.New...
    Johnson and Johnson hit with whooping USD 8 billion verdict over antipsychotic drug Risperda

    Johnson and Johnson hit with whooping USD 8 billion verdict over antipsychotic drug Risperda

    Medical Dialogues Bureau9 Oct 2019 10:54 AM GMT
    Johnson and Johnson said the award was "grossly disproportionate with the initial compensatory award in this case, and the company is confident it...
    JnJ pledges USD 500 million investment to eliminate HIV, TB by 2030

    JnJ pledges USD 500 million investment to eliminate HIV, TB by 2030

    Medical Dialogues Bureau7 Oct 2019 4:00 AM GMT
    NEW BRUNSWICK: Johnson & Johnson (JnJ) recently announced it has committed to ensuring more than $500 million is dedicated to world-class research...
    Natco Pharma files ANDA for generic version of Bosentan tablets for oral suspension

    Natco Pharma files ANDA for generic version of Bosentan tablets for oral suspension

    Farhat Nasim5 Jun 2019 4:30 AM GMT
    Bosentan 32 mg tablets are sold by Actelion Pharmaceuticals US, Inc. (acquired by Johnson and Johnson) under the brand name Tracleer.Hyderabad:...
    MORE TEARS: After Talcum Powder, JnJ Baby Shampoo reveals presence of Carcinogens

    MORE TEARS: After Talcum Powder, JnJ Baby Shampoo reveals presence of Carcinogens

    Meghna A Singhania3 April 2019 11:00 AM GMT
    New Delhi: After facing trouble with its baby talcum powder amid allegations that it contains asbestos, US healthcare giant Johnson and Johnson (JnJ)...
    JnJ Faulty Hip Implants: 7 more patients found fit for compensation

    JnJ Faulty Hip Implants: 7 more patients found fit for compensation

    Meghna A Singhania30 March 2019 7:45 AM GMT
    Mumbai: Several patients who claim to be suffering due to faulty hip implants manufactured by Johnson and Johnson (JnJ) have been claiming...
    Cancer Causing Talcum Powder: JnJ gets New Jersey jury relief

    Cancer Causing Talcum Powder: JnJ gets New Jersey jury relief

    Medical Dialogues Bureau29 March 2019 6:10 AM GMT
    JnJ on Wednesday also settled three other mesothelioma talc cases pending in state courts in California, Oklahoma and New York, Chris Panatier, a...
    J&J passes asbestos test, allowed to make baby powder in India

    J&J passes asbestos test, allowed to make baby powder in India

    Farhat Nasim1 March 2019 8:58 AM GMT
    NEW DELHI: In a major relief to Johnson & Johnson(J&J), no asbestos was found in the baby powder manufactured in Baddi and Mulund plants. The...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok